These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Antigenicity tests of suplatast tosilate (IPD-1151T)]. Kouchi Y; Ohuchida A; Maeda Y; Katayama S; Kurokawa M; Mizumoto T; Nakagawa M; Manabe H; Sugimoto S; Yoshida R J Toxicol Sci; 1992 May; 17 Suppl 2():221-33. PubMed ID: 1321263 [TBL] [Abstract][Full Text] [Related]
4. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response. Yanagihara Y; Kiniwa M; Ikizawa K; Yamaya H; Shida T; Matsuura N; Koda A Jpn J Pharmacol; 1993 Jan; 61(1):23-30. PubMed ID: 8382322 [TBL] [Abstract][Full Text] [Related]
5. [Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice]. Matsuura N; Mori H; Nagai H; Koda A Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):485-93. PubMed ID: 1336470 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells]. Kouno S; Adachi M; Asano K; Okamoto K; Takahashi T Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362 [TBL] [Abstract][Full Text] [Related]
7. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice. Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009 [TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp. Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380 [TBL] [Abstract][Full Text] [Related]
9. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response. Yanagihara Y; Kiniwa M; Ikizawa K; Shida T; Matsuura N; Koda A Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323 [TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes. Konno S; Adachi M; Asano K; Gonogami Y; Ikeda K; Okamoto K; Takahashi T Eur J Pharmacol; 1994 Jun; 259(1):15-20. PubMed ID: 7957588 [TBL] [Abstract][Full Text] [Related]
11. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate. Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370 [TBL] [Abstract][Full Text] [Related]
12. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils. Shichijo M; Shimizu Y; Hiramatsu K; Togawa M; Inagaki N; Takagi K; Nagai H Jpn J Pharmacol; 1999 Apr; 79(4):501-4. PubMed ID: 10361893 [TBL] [Abstract][Full Text] [Related]
13. [Effect of KC-404 on allergic reactions types I-IV]. Nishino K; Hara S; Irikura T Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160 [TBL] [Abstract][Full Text] [Related]
14. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742 [TBL] [Abstract][Full Text] [Related]
15. IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Koda A; Yanagihara Y; Matsuura N Agents Actions Suppl; 1991; 34():369-78. PubMed ID: 1665310 [TBL] [Abstract][Full Text] [Related]
16. [Mutagenicity tests of suplatast tosilate (IPD-1151T)]. Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534 [TBL] [Abstract][Full Text] [Related]
18. [Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (1)--Fertility study in rats by oral administration]. Aso S; Sueta S; Kajiwara Y; Morita S; Horiwaki S; Yamakita O J Toxicol Sci; 1992 May; 17 Suppl 2():141-54. PubMed ID: 1321258 [TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiallergic activity of dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-toluenesulfonate derivatives. Tada Y; Yamawaki I; Ueda S; Matsumoto H; Matsuura N; Yasumoto M; Koda A; Hori M J Med Chem; 1998 Aug; 41(18):3330-6. PubMed ID: 9719585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]